Our services
We offer a range of services tailored to your needs.
Radiopharmium provides expert consulting and innovative solutions for the development and production of radiopharmaceuticals.
How we work with clients
Most engagements take one of three forms. Tell us the problem and we will suggest which fits. Most engagements begin with a call and a short written scope.
A defined project
Scoped and priced up front, for a specific piece of chemistry, process development or documentation, including advisory support for a facility build for research or GMP radiopharmaceutical manufacture.
A fractional retainer
Typically one to three days a month, where we hold a named leadership role in your organisation.
An advisory day
Used for technical review, board-level input or a second opinion before a decision.
For companies, startups & innovators.
We can join your Scientific Advisory Board (SAB), or support your company through fractional leadership, ideal for startups and growing organisations at the early stages of their journey. We provide senior-level expertise without the need for a full-time hire. Through our fractional CSO model, you gain flexible, fit-for-purpose scientific leadership tailored to your needs.
We advise or set scientific strategy
Establish a clear R&D roadmap that supports long-term business objectives.
We drive innovation
Identify and advance promising research opportunities with strong translational potential.
We ensure compliance
Oversee regulatory, quality and documentation requirements to keep development on track.
We build and lead teams
Recruit, mentor and manage scientific staff to create high-performing teams.
We secure resources
Support fundraising efforts, grant applications and strategic partnerships to fund R&D.
We deliver milestones
Manage projects to meet key development goals and give confidence to investors and stakeholders.
For funders, investors & venture capitalists.
Radiopharmium helps investors make informed decisions in one of the most complex areas of life sciences. We provide independent scientific and technical due diligence, assessing the strengths, risks and opportunities of potential investments. Our expertise bridges the gap between innovation and clinical application, giving you confidence that portfolio companies are built on sound science and realistic development pathways.
The questions we answer
- Is the radiolabelling chemistry reproducible at the scale the plan assumes?
- Does the isotope supply exist, in the quantities and at the activity needed?
- Is the proposed manufacturing route compatible with the isotope half-life and the distribution model?
- Is the regulatory pathway costed and timed realistically?
- Does the team have the manufacturing experience the plan requires, or is that a hire that has not been budgeted?